Inflammation in cystic fibrosis is a predictor of mortality and targeted with CFTR modulator therapy

Daniel Cook from Vanderbilt University Medical Center, Nashville, Tennessee, USA, presents their research findings published in Allergy: Cook, D.P., Wu, A.Y., Thomas, C.M., Hamilton, R.G., Stokes Peebles, R., Jr and Kerchberger, V.E. (2024), Type 2 inflammation in cystic fibrosis is a predictor of mortality and targeted with CFTR modulator therapy. Allergy. doi.org/10.1111/all.16198 Follow Allergy on: Facebook: www.facebook.com/EAACIAllergy Twitter: twitter.com/AllergyEaaci LinkedIn: www.linkedin.com/company/allergy-eaaci Instagram: www.instagram.com/allergy.eaaci Like, share and comment on our videos, thank you. journalallergy.com/